PATENT CLAIM ANALYSIS

Application Number: 16438135
Application Type: Utility
Filing Date: 2019-06
Publication Date: 2019-10
Patent Classification: ["544", "281000"]

Abstract:
Compounds of Formula (00A) and methods of use as Janus kinase inhibitors are described herein.

Claim (Index 9):
The compound of  claim 1 , further defined as a compound of Formula (VIII): wherein:\n R 1h  is selected from the group consisting of H and C 1 -C 6  alkyl optionally substituted by CN, 3-6 membered cycloalkyl, or 4-6 membered heterocycloalkylene-C(O)O\u2014(C 1 -C 6  alkylene)-phenyl; \n Ring C is 3-7 membered cycloalkyl or 3-7 membered heterocycloalkyl; and \n Ring D is a 3-7 membered heterocycloalkyl substituted at the sole nitrogen by R 1h ; and \n provided Rings C and D together form a 3-11 membered spiro heterocycloalkyl.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 100.0
- Lexical Diversity: 1.05882
- Patent Class: 544.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15139164', '15543826', '14904801', '14451600', '15257926']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8113540263515259
- 35 USC 102 Novelty (BERT): 0.5773380470644013
- Combined Prediction Score: 0.7879524284228134
- Mean Citation Score: 405.063252
- Max Citation Score: 495.0762
- Similarity Product: 394.2864517459631

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test